Risk Factors for Extensive Drug-resistance and Mortality in Geriatric Inpatients with Bacteremia Caused by Acinetobacter Baumannii
Overview
Authors
Affiliations
Background: The aim of this study was to explore the risk factors for developing bacteremia caused by extensive drug-resistant (XDR) Acinetobacter baumannii and the associated mortality in geriatric inpatients.
Methods: We conducted a retrospective study of 125 patients with A baumannii bacteremia between October 2008 and December 2013 at a medical center in China.
Results: The 30-day hospital mortality rate was 55.2%. XDR A baumannii was detected in 31.2% of all cases. A logistic regression analysis suggested that chronic obstructive pulmonary disease, a bedridden status, and central venous catheters were associated with bacteremia caused by XDR A baumannii, with adjusted odds ratios (aORs) and 95% confidence intervals (CIs) of 2.59 (1.01-6.64), 4.08 (1.39-12.01), and 9.52 (1.90-47.56), respectively. Furthermore, intensive care unit (ICU) stay, bacteremia caused by XDR A baumannii, concurrent fungal infection, and age (70-80 years old and >80 years old) were associated with mortality, with aORs and 95% CIs of 3.16 (1.29-7.73), 4.01 (1.46-11.04), 3.20 (1.28-7.98), 4.31 (1.44-12.92), and 5.46 (1.94-15.35), respectively.
Conclusion: Bacteremia is associated with a high 30-day hospital mortality rate in geriatric inpatients. Furthermore, ICU stay, bacteremia caused by XDR A baumannii, concurrent fungal infection, and age are associated with increased mortality in geriatric inpatients with A baumannii bacteremia.
Multidrug-Resistant : Risk Factors for Mortality in a Tertiary Care Teaching Hospital.
cerniauskiene K, Vitkauskiene A Trop Med Infect Dis. 2025; 10(1).
PMID: 39852666 PMC: 11768767. DOI: 10.3390/tropicalmed10010015.
Risk factors and predictive model for nosocomial infections by extensively drug-resistant .
Shi J, Mao X, Cheng J, Shao L, Shan X, Zhu Y Front Cell Infect Microbiol. 2024; 14:1475428.
PMID: 39403207 PMC: 11471650. DOI: 10.3389/fcimb.2024.1475428.
Kaki R Access Microbiol. 2024; 6(9).
PMID: 39351343 PMC: 11441443. DOI: 10.1099/acmi.0.000826.v4.
Allel K, Stone J, Undurraga E, Day L, Moore C, Lin L PLoS Med. 2023; 20(6):e1004199.
PMID: 37347726 PMC: 10287017. DOI: 10.1371/journal.pmed.1004199.
Minocycline and the SPR741 Adjuvant Are an Efficacious Antibacterial Combination for Infections.
Alamneh Y, Antonic V, Garry B, Pucci M, Abu-Taleb R, Shearer J Antibiotics (Basel). 2022; 11(9).
PMID: 36140032 PMC: 9495173. DOI: 10.3390/antibiotics11091251.